Abstract

AimThe differentiation of destruction-induced thyrotoxicosis and Graves’ disease (GD) is of great importance for selection of proper therapy. Radioactive iodine uptake (RAIU) is the gold standard for differentiating these two conditions but its application has remained somewhat limited. Thyroid color Doppler flow sonography (CDFS) is a potential alternative of RAIU but more supporting evidence is warranted. In the present study, a standard operative procedure was developed to measure the mean peak systolic velocity of superior thyroid artery (STA-PSV) and evaluate its role in the differential diagnosis of thyrotoxicosis.MethodsA total of 135 patients with untreated thyrotoxicosis were enrolled into one retrospective study (GD, n = 103; thyroiditis, n = 32) and another prospective study recruited 169 patients (GD, n = 118; thyroiditis, n = 51). Thirty normal controls were also enrolled. Thyroid function, anti-TSH-receptor antibody (TRAb), RAIU, CFDS of thyroid and STA-PSV were performed for each patient. Receiver operator curve (ROC) was used to evaluate the diagnostic value of STA-PSV in a retrospective study so as to seek the optimal cutoff point. Then the cutoff point value was used to validate its diagnostic value in a prospective study and in another thyrotoxicosis population.ResultsSTA-PSV of GD was significantly higher than that of thyroiditis in both retrospective and prospective studies. The area under the ROC curve of mean STA-PSV was 0.8799 and 0.9447 in the retrospective and prospective studies respectively. If a mean STA-PSV cutoff point of 50.5 cm/s was set from the retrospective analysis for the prospective study, the sensitivity and specificity in distinguishing GD from thyroiditis were 81.04% and 96.08% respectively. Mean STA-PSV and TRAb had similar area under ROC. The coefficients of variation in STA-PSV measurement were lower than 10% for the euthyroid, thyroiditis and GD groups.ConclusionsSTA-PSV is a feasible supplement alternative of RAIU for differentiating the causes of thyrotoxicosis.

Highlights

  • As mentioned in the 2011 ATA (American Thyroid Association) guideline, the color Doppler flow sonography (CDFS) of thyroid, as an indicator of thyroid blood flow status, has some practical values in the differentiation of thyrotoxicosis

  • Anti-TSH-receptor antibody (TRAb), Radioactive iodine uptake (RAIU), CFDS of thyroid and STA-peak systolic velocity (PSV) were performed for each patient

  • If a mean STA-PSV cutoff point of 50.5 cm/s was set from the retrospective analysis for the prospective study, the sensitivity and specificity in distinguishing Graves’ disease (GD) from thyroiditis were 81.04% and 96.08% respectively

Read more

Summary

Introduction

As mentioned in the 2011 ATA (American Thyroid Association) guideline, the color Doppler flow sonography (CDFS) of thyroid, as an indicator of thyroid blood flow status, has some practical values in the differentiation of thyrotoxicosis. Due to lack of well-designed and evidence-based diagnostic trials, official recommendation is not made. It is only limited to the differentiation of some special circumstances, such as amiodarone-induced thyroiditis [1]. From the perspectives of clinical trial design, the previous studies were mainly descriptive and were lack of ROC curve analysis [2,3]. There was no validation of the study conclusions among another population [2,3,4]. Reproducibility analysis was not performed for the measurement

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.